MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Effects of Eromomastax speciosa in a Gastric Ulcer in a 6-hydroxydopamine (6-OHDA)-induced Rat Model of Parkinson’s Disease.

    GL. Ndji Otto, P. Amang, H. Adjia (Bertoua, Cameroon)

    Objective: To investigate the extract of Eromomastax speciosa neuroprotective/gastroprotective potential in the indomethacin (IND)-induced gastric ulcer in a 6-hydroxydopamine (6-OHDA)-induced PD model. Background: Parkinson's disease…
  • 2023 International Congress

    Arm swing deviations in patients with PD at different gait velocities

    S. Mainka, G. Ebersbach (Beelitz-Heilstaetten, Germany)

    Objective: To assess bilateral arm swing (AS) and other gait parameters in patients with PD and healthy subjects (HS) at various gait speeds and to…
  • 2023 International Congress

    Identification of reproducible metabolites for Parkinson’s Disease diagnosis using clinical data and computational modelling

    X. Luo, YJ. Liu, A. Balck, C. Klein, R. Fleming (Galway, Ireland)

    Objective: To identify replicated metabolic markers of Parkinson’s Disease (PD) diagnosis from metabolomic studies and predict additional metabolic markers using computational metabolic modelling. Background: Reported metabolic markers of…
  • 2023 International Congress

    Country and Sex Differences in Diagnosis Latency of Parkinson’s Disease in Latin American Populations

    J. Ramchandra, M. Inca-Martinez, TP. Leal, E. Gatto, F. Micheli, BL. Santos-Lobato, F. Cardoso, G. Letro, P. Braga-Neto, V. Peixoto, AF. Schumacher-Schuh, C. Rieder, V. Tumas, V. Borges, P. Chana, P. Saffie, P. Olguin, A. Colombo, JL. Orozco Vélez, C. Velez-Pardo, M. Del Rio, A. Medina, M. Rodriguez-Violante, AJ. Hernandez-Medrano, D. Martinez-Ramirez, A. Ruiz-Contreras, A. Lazaro-Figueroa, P. Reyes, M. Cornejo-Olivas, AC. Medina Colque, JE. Rios Pinto, A. Viñuela, IF. Mata (Cleveland, USA)

    Objective: To compare the latency in Parkinson’s Disease (PD) diagnosis, from onset of motor symptoms to clinical diagnosis, by sex in Latin America. Background: In…
  • 2023 International Congress

    Accelerometric Classification of Resting and Postural Tremor in Essential Tremor and Parkinson’s Disease

    C. Hennen, T. Berger, GA. Brandt, JN. Strelow, H. Jergas, JC. Baldermann, MT. Barbe, JN. Petry-Schmelzer, TA. Dembek (Cologne, Germany)

    Objective: To investigate the predictive value of different accelerometry metrics for clinical ratings of Essential Tremor (ET) and tremor in Parkinson’s Disease (PD). Background: To…
  • 2023 International Congress

    Real-world utility of MANAGE PD tool by physicians and patients in Germany

    M. Südmeyer, D. Pedrosa, F. Siebecker, C. Arlt, J. Kopra, W. Jost (Potsdam, Germany)

    Objective: To investigate the utility of the MANAGE PD tool in routine clinical care in Germany and the planned next steps after the tool recommendation.…
  • 2023 International Congress

    Parkinson’s disease: cardiorespiratory fitness, respiratory muscle strength and lung capacity after a high-intensity Aquatic Physiotherapeutic Exercise Program (APEP/PEFA)

    L. Paladini, T. Christinelli, G. Leveck, V. Israel (CURITIBA, Brazil)

    Objective: To compare cardiorespiratory fitness (CF), respiratory muscle strength and lung capacity (LC) after a high-intensity Aquatic Physiotherapeutic Exercise Program (APEP/PEFA). Background: Dopaminergic degeneration and…
  • 2023 International Congress

    SLC1A7 mutation is a cause of the autosomal dominant form of Parkinson’s disease

    A. Kishore, M. Marc Sturm, F. Raimondi, P. Lichtner, A. Sreelatha, N. Casadei, C. Blauwendraat, G. Sarma, R. Kruger, A. Zimprich, A. Singleton, T. Gasser, O. Riess, M. Sharma (Kochi, India)

    Objective: To identify novel genes involved in the familial form of Parkinson’s disease (PD) in the Indian population. Background: Most of the familial forms of…
  • 2023 International Congress

    Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease

    K. Brockmann, JC. Corvol, A. Difonzo, S. Durrleman, T. Gasser, M. Hu, R. Krüger, I. Liepelt-Scarfone, M. Matarazzo, A. Pilotto, T. Simuni, P. Svenningsson, D. Weintraub, G. Pagano (Tuebingen, Germany)

    Objective: To prevent cognitive decline in GBA-associated Parkinson’s Disease (PD). Background: Dementia represents a key milestone in the course of PD with limited effective treatments…
  • 2023 International Congress

    The Synuclein-One Study: Detection of Cutaneous Phosphorylated alpha-synuclein for the Diagnosis of the Synucleinopathies

    R. Freeman, T. Levine, J. Stohl, B. Bellaire, C. Gibbons (BOSTON, USA)

    Objective: The Synuclein-One study is an NIH-funded 30-site, multicenter trial of 428 patients with synucleinopathies  including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple…
  • « Previous Page
  • 1
  • …
  • 218
  • 219
  • 220
  • 221
  • 222
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley